arrow_back Back Filing freshness 20-F FY 2026 SEC EDGAR

download Export Data

China SXT Pharmaceuticals, Inc.

SXTC

$0.04 ▼ -0.01 (-17.29%) at close

11 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Neutral

auto_awesome

Analytical Summary

China SXT Pharmaceuticals, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth -34.6% ↘

Op. Margin None

ROIC -18.5% ↘

FCF / Share $-5.91 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity 0.03

info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.14M

↓ -34.6% —

Net Income Profit after all expenses

$-6.21M

↓ -87.8% —

Operating Margin Operating profit as % of sales

-154.0%

↓ -18.1% —

FCF / Share Free cash flow per share

$-5.91

↓ -258.7% —

Long-Term Debt Long-term obligations

$644.39K

↓ -20.2% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability

Returns ↑

Financial Health →

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Mar 31, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Mar 31, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗
Revenue Growth YoY (%)	-34.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-533%)	-9.7% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-222%)	-2.2% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-127%)	-24.2% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-403%)	-45.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-669%)	-7.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-193%)	-26.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-430%)	-0.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-101%)	43.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+447%)	—	—
EPS Growth YoY (%)	-293.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	91.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-28.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	44.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-87.8% Weak ↓ Weak Declining Year-over-year change in net income	-6.6% Weak ↑ Weak Improving Year-over-year change in net income	47.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-3.5% Weak ↑ Weak Improving Year-over-year change in net income	-108.7% Weak ↓ Weak Declining Year-over-year change in net income	73.3% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	29.6% Excellent Excellent Year-over-year change in net income	0.2% Caution Caution Year-over-year change in net income	—	—
FCF Growth YoY (%)	-258.7% Weak ↑ Weak Improving Year-over-year change in free cash flow	90.7% Excellent Excellent Year-over-year change in free cash flow	-5778.5% Weak Weak Year-over-year change in free cash flow	N/M	N/M	—	—	—	1203.4% Excellent Excellent Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	-16.7% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-12.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-26.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-27.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-28.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-12.0% Weak Weak Compound annual revenue growth over 3 years	1.9% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-24.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-19.5% Weak → Weak Stable Compound annual revenue growth over 5 years	-22.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-22.4% Weak Weak Compound annual revenue growth over 5 years	-11.8% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	—	301.5% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Mar 31, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Mar 31, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗
Operating Margin (%) (%)	—	-154.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1126%)	-130.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-969%)	-284.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1996%)	-199.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1430%)	-46.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-407%)	-26.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-273%)	25.2% Excellent ↓ Excellent Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+68%)	23.3% Good Good Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+55%)	32.8% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+119%)	—
Effective Tax Rate (%) (%)	—	—	—	—	-6.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	—	-189.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1681%)	-160.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1439%)	-301.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2608%)	-220.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1937%)	-57.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-579%)	-199.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1761%)	22.0% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+83%)	16.9% Good Good Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+41%)	24.3% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+102%)	—
FCF Margin (%) (%)	-353.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-134.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-100.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-4.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	10.3% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-27.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	18.1% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	-4.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	21.1% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	2.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.65x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.09x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.25x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Mar 31, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Mar 31, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗
Return on Invested Capital (%)	-18.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-13.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	39.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	68.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-20.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	10.1% Good Good Operating profit relative to total assets Optimal: > 10%	21.3% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-20.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-239%)	-21.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-22.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-248%)	-40.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-369%)	-34.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-333%)	-17.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	-109.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-830%)	13.9% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-8%)	36.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+141%)	64.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+326%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Mar 31, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Mar 31, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗
Debt to Equity (x)	0.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.10x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-84%)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.02x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	—	—	—
Interest Coverage (x)	-332.06x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-25.23x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.86x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-429.79x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-141.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.36x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.40x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	342.00x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	2095.34x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	39.67x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-27.18M	$-16.59M	$-11.46M	$-17.08M	$11.40K	$43.41K	$-7.21M	$-9.06M	$-560.25K	$-65.57K	$-11.44K
Debt / EBITDA (x)	-0.14x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.58x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.26x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.05x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.08x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.04x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Mar 31, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Mar 31, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗
Revenue per Share (USD)	$1.67	$1.22	$17.79	$7.39	$2.50	$6.64	—	—	$0.35	$0.24	—
Basic EPS, GAAP (USD)	$-9.13	$-2.32	$-28.58	$-22.23	$5.52	$3.82	—	—	$0.06	$0.06	—
Free Cash Flow per Share (USD)	$-5.91	$-1.65	$-17.78	$-0.30	$0.26	$-1.83	—	—	$0.07	$0.01	—
Book Value per Share (USD)	$43.71	$1.12	$1.01	$32.12	$8.09	$20.56	$1.08	$0.49	$0.16	$0.09	—
Tangible Book Value per Share (USD)	$43.70	$1.12	$1.01	$32.06	$8.09	$20.56	$1.08	$0.49	$0.16	$0.09	—
Basic Weighted Avg Shares (shares)	679,648	1.42M	108,428	266,973	1.04M	719,549	—	—	20.00M	20.00M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Mar 31, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Mar 31, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗
Working Capital (USD)	$30.16M	$15.28M	$5.33M	$5.02M	$5.33M	$4.65M	$7.37M	$9.27M	$1.73M	—	—
LT Debt (USD)	$644.39K	$807.23K	$117.13K	$117.86K	—	$6.29K	$36.51K	$41.71K	—	—	—
Total Equity (USD)	$29.71M	$15.44M	$13.93M	$14.69M	$16.42M	$15.96M	$9.40M	$11.11M	$3.29M	$1.85M	$742.77K

📋 What is driving earnings? 4 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Mar 31, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Mar 31, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗
Sales/Revenue/Turnover (USD)	$1.14M	$1.74M	$1.93M	$1.97M	$2.60M	$4.78M	$5.16M	$7.01M	$7.02M	$4.88M	—
Depreciation Expense (USD)	$73.67K	$82.30K	$203.25K	$250.16K	$320.01K	$345.41K	$331.84K	$180.92K	$123.27K	$94.41K	—
Net Income, GAAP (USD)	$-6.21M	$-3.30M	$-3.10M	$-5.93M	$-5.74M	$-2.75M	$-10.29M	$1.54M	$1.19M	$1.19M	—
Operating Cash Flow (USD)	$-4.02M	$-2.35M	$-1.93M	$-80.76K	$268.29K	$-1.32M	$934.25K	$239.19K	$1.92M	$293.04K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 11 quarters

China SXT Pharmaceuticals, Inc.

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SXTC with peers